Electronic Arts Gags on 'Poison Pill'

Schachter, Ken
March 2008
Red Herring;3/28/2008, p2
Trade Publication
The article reports that Electronic Arts (EA) has maintained its takeover offer for Take-Two Interactive Software. EA argued that its $26 per share offer, which is a 64 percent premium over Take-Two's closing stock price, represents fair value. However, EA threatened to withdraw its offer if Take-Two does not drop its poison pill or shareholder rights program.


Related Articles

  • EA Bids $1.9 Billion for Take-Two Interactive.  // Red Herring;2/25/2008, p6 

    The article reports on the unsolicited bid offered by video game firm Electronic Arts offer for video game publisher Take-Two Interactive Software. Electronic Arts issued a $1.9 billion offer or Take-Two, which is said to be its response to Activision's $18 billion acquisition of the gaming unit...

  • Take-Two Rejects EA's $2B Bid. Schachter, Ken // Red Herring;2/25/2008, p3 

    The article reports on the decision of the board of Take-Two Interactive Software to reject the $2 billion buyout offer of Electronics Arts. Take-Two claims that the $26 per share cash offer issued by Electronic Arts undervalues the company's game franchises. After such decision, the shares of...

  • Acquisition plans bring shared angst. Fritz, Ben // Variety;4/14/2008, Vol. 410 Issue 9, p4 

    This article reports on acquisition offers made to web portal Yahoo by Microsoft and to videogame publisher Take-Two Interactive by Electronic Arts (EA). In both cases, management initially rejected purchase offers and both EA and Microsoft may have to take their offers to shareholders. The...

  • Analysts: "poison pill" buys time for Navistar. Kilcarr, Sean // Fleet Owner Blog;6/22/2012, p8 

    The article discusses Navistar's shareholder rights plan, also known as a "poison pill," and how analysts view it. It notes that the company has revealed that the plan as a way to prevent coercive takeover tactics which may lead to unfair share prices for its stockholders. Stern Agee analyst...

  • How to Deal With Unwanted Suitors. Cody, Tamika // Investment Dealers' Digest;3/11/2011, Vol. 77 Issue 10, p8 

    The article focuses on the use of poison pills strategy to deter unwanted offers in company mergers and acquisitions in the U.S. According to the author, a ruling by the Delaware Court of Chancery encourages companies to use poison pills such as shareholder rights plan to avoid being targeted by...

  • POISON PILL PROTEST. Learmonth, Michael // Daily Variety;10/24/2005, Vol. 289 Issue 16, p5 

    Focuses on the decision of disgruntled shareholders of News Corp. Ltd. to protest over the 'poison pill' provision enacted to prevent a hostile takeover by cable television dealer John Malone in the U.S. Accusations against company chairman Rupert Murdoch on breaking a promise to put the poison...

  • The Poison Pill as Shield and Gavel. Kearney, Mark A. // Directors & Boards;Summer89, Vol. 13 Issue 4, p40 

    The article presents a guide to the key decisions on the uses of poison pills and when boards may redeem them. By definition, poison pills provide shareholders certain rights upon the development of specified triggering events. The various forms of poison pills like a flipover, a flip-in and the...

  • Game On for EA and Take-Two? Schachter, Ken // Red Herring;3/27/2008, p5 

    The article reports on the possible acquisition of Take-Two Interactive Software by Electronic Arts (EA). In a government filing, EA said its $26 per share offer is full and fair. However the board and financial advisors Bear Stearns and Lehman Brothers of Take-Two see the offer as inadequate....

  • This time, EA turns hostile. Bond, Paul // Hollywood Reporter -- International Edition;3/14/2008, Vol. 403 Issue 48, p4 

    The article reports on the second time offer made by Electronic Arts Inc. (EA) for the acquisition of Take Two Interactive Software Inc. EA made a conditional offer to buy Take Two at $26 a share or $2 billion, the same price Take Two executives and chairperson Strauss Zelnick already have...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics